Inhaled TD139
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Galecto Biotech AB
Overview
Inhaled TD139 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Inhaled TD139 clinical trials
Explore related
Medical disclaimer. This page summarizes research about Inhaled TD139 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.